首页> 外文期刊>Alcohol >Changes of four common non-infectious liver diseases for the hospitalized patients in Beijing 302 hospital from 2002 to 2013
【24h】

Changes of four common non-infectious liver diseases for the hospitalized patients in Beijing 302 hospital from 2002 to 2013

机译:2002年至2013年北京302医院住院患者四种常见非传染性肝病的变化

获取原文
获取原文并翻译 | 示例
           

摘要

The implementation of a hepatitis B vaccination program in China has led to a significant decline in the prevalence and incidence of liver diseases secondary to hepatitis B virus over the past two decades. With recent changes in the economy and increases in average incomes in China during the same period, there has been a rapid rise in per capita alcohol consumption and an epidemic of obesity. We hypothesized that the burden of liver diseases in China has shifted from infectious to non-infectious etiologies. We retrospectively analyzed the data of 20,378 patients who were hospitalized in Beijing 302 hospital between 2002 and 2013. We found that the total admission rate secondary to alcoholic liver disease (ALD), non-alcoholic liver disease (NAFLD), autoimmune liver disease (AILD), and drug-induced liver injury (DILI) was 10.7%. ALD was the leading cause of inpatient hospitalization (3.9% of total admissions). The rate of inpatient admission for ALD, AILD, and DILI increased by 170%, 111%, and 107%, respectively during the study period. Chinese herbal medicine was the primary cause of DILI in our subjects. The burden of non-infectious liver diseases has increased over the last decade among hospitalized patients in a large tertiary hospital in China. The increase in the rate of admission for ALD and DILI from Chinese herbal medicine suggests that strategies to reduce harmful use of alcohol and increase awareness and education on the use of herbal medicine are needed. (C) 2016 Elsevier Inc. All rights reserved.
机译:在过去二十年中,中国在中国实施乙型肝炎疫苗接种计划的实施导致肝脏疾病的肝病患病率和发病率显着下降。随着近期经济的变化和中国平均收入的增加,人均酒精消费和肥胖流行病迅速上升。我们假设中国肝病的负担从传染病转向非传染性病因。我们回顾性分析了2002年至2013年间在北京302医院住院的20,378名患者的数据。我们发现患有酒精性肝病(ALD),非酒精性肝病(NAFLD),自身免疫性肝病(AILD)的总入学率)和药物诱导的肝损伤(Dili)为10.7%。 ALD是住院住院治疗的主要原因(占总入学总额的3.9%)。在研究期间,ALD,Aild和Dili的住院入住率分别增加了170%,111%和107%。中草药是我们受试者中帝力的主要原因。非传染性肝病的负担在过去十年中,在中国的一家大型高等院医院的住院患者中的过去十年增加。需要增加中国草药的ALD和Dili的入学率,旨在减少减少酒精的有害和提高对草药的认识和教育的策略。 (c)2016年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号